Primary prevention of cardiovascular disease with statins: cautionary notes
Autor: | Luca Mascitelli, Mark R. Goldstein, Francesca Pezzetta |
---|---|
Rok vydání: | 2009 |
Předmět: | |
Zdroj: | QJM. 102:817-820 |
ISSN: | 1460-2393 1460-2725 |
Popis: | Sir, In his informative commentary on the importance of primary prevention in reducing the burden of vascular disease,1 Dr Miller states that compliance problems with lifestyle changes facilitate the pharmacologic treatment with statins to achieve low-density lipoprotein (LDL) cholesterol lowering goals. It's noteworthy that prominent thought leaders now suggest that 100 million Americans should be on statin therapy (instead of the 16 million Americans presently on statin therapy) and everyone should have a LDL cholesterol level |
Databáze: | OpenAIRE |
Externí odkaz: |